UPD registration guide for UI and API users
Submitted by Anonymous (not verified) on 22 October 2024 - 13:32
UPD registration guide for UI and API users
Clinical Trial Information System (CTIS) structured data form - Initial application, additional Member State Concerned, substantial modification, non-substantial modification
Submitted by Anonymous (not verified) on 22 October 2024 - 12:23
Clinical Trial Information System (CTIS) structured data form - Initial application, additional Member State Concerned, substantial modification, non-substantial modification
Big data training curriculum
Submitted by Anonymous (not verified) on 22 October 2024 - 10:07
Big data training curriculum
Human medicines European public assessment report (EPAR): Zydelig, idelalisib, Date of authorisation: 18/09/2014, Revision: 21, Status: Authorised
Submitted by Anonymous (not verified) on 21 October 2024 - 15:22
Human medicines European public assessment report (EPAR): Zydelig, idelalisib, Date of authorisation: 18/09/2014, Revision: 21, Status: Authorised
Human medicines European public assessment report (EPAR): Amyvid, florbetapir (18F), Date of authorisation: 14/01/2013, Revision: 15, Status: Authorised
Submitted by Anonymous (not verified) on 21 October 2024 - 11:50
Human medicines European public assessment report (EPAR): Amyvid, florbetapir (18F), Date of authorisation: 14/01/2013, Revision: 15, Status: Authorised
Agenda - ACT EU multi-stakeholder platform annual meeting
Submitted by Anonymous (not verified) on 21 October 2024 - 11:15
Agenda - ACT EU multi-stakeholder platform annual meeting
Quality Drafting Group
Submitted by Anonymous (not verified) on 21 October 2024 - 8:24
Quality Drafting Group
Three-year work plan for the Quality Drafting Group (QDG) of the Committee on Herbal Medicinal Products (HMPC)
Submitted by Anonymous (not verified) on 21 October 2024 - 8:22
Three-year work plan for the Quality Drafting Group (QDG) of the Committee on Herbal Medicinal Products (HMPC)
Veterinary medicines European public assessment report (EPAR): Purevax RC, vaccine against feline viral rhinotracheitis and feline calicivirosis, Status: Authorised
Submitted by Anonymous (not verified) on 18 October 2024 - 15:51
Veterinary medicines European public assessment report (EPAR): Purevax RC, vaccine against feline viral rhinotracheitis and feline calicivirosis, Status: Authorised
Questions and answers about the clinical study data proof-of-concept pilot for industry
Submitted by Anonymous (not verified) on 18 October 2024 - 15:48
Questions and answers about the clinical study data proof-of-concept pilot for industry